0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Hydrocortisone Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-22E5764
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Hydrocortisone Market Insights and Forecast to 2028
BUY CHAPTERS

Global Hydrocortisone Market Research Report 2025

Code: QYRE-Auto-22E5764
Report
September 2025
Pages:120
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Hydrocortisone Market

The global market for Hydrocortisone was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Hydrocortisone is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Hydrocortisone is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Hydrocortisone in Adrenocortical Dysfunction is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Hydrocortisone include Pfizer, Sanofi, Teva, Akorn, GSK, Bausch and Lomb, Bayer Pharmas, Macleods Pharmaceuticals, Casper Pharma, Dow Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Hydrocortisone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hydrocortisone.
The Hydrocortisone market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hydrocortisone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hydrocortisone companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Hydrocortisone Market Report

Report Metric Details
Report Name Hydrocortisone Market
Segment by Type
  • Cream
  • Injection
  • Table
Segment by Application
  • Adrenocortical Dysfunction
  • Adrenergic Syndrome
  • High Blood Calcium
  • Thyroiditis
  • Rheumatoid Arthritis
  • Dermatitis
  • Asthma and Chronic Obstructive Pulmonary Disease
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer, Sanofi, Teva, Akorn, GSK, Bausch and Lomb, Bayer Pharmas, Macleods Pharmaceuticals, Casper Pharma, Dow Pharma, Fougera Pharms, Hikma Intl Pharms, Impax Labs, Ivax Pharms, Lannett, Merck, Novartis, Salix Pharms, Sandoz, TARO, Valeant, Wockhardt, Farmak JSC, Solvay Pharma, Alcon, Paladin Labs, Adcock Ingram, ADARE Pharmaceuticals, Aspen Holdings, Astellas Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Hydrocortisone company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Hydrocortisone Market report?

Ans: The main players in the Hydrocortisone Market are Pfizer, Sanofi, Teva, Akorn, GSK, Bausch and Lomb, Bayer Pharmas, Macleods Pharmaceuticals, Casper Pharma, Dow Pharma, Fougera Pharms, Hikma Intl Pharms, Impax Labs, Ivax Pharms, Lannett, Merck, Novartis, Salix Pharms, Sandoz, TARO, Valeant, Wockhardt, Farmak JSC, Solvay Pharma, Alcon, Paladin Labs, Adcock Ingram, ADARE Pharmaceuticals, Aspen Holdings, Astellas Pharma

What are the Application segmentation covered in the Hydrocortisone Market report?

Ans: The Applications covered in the Hydrocortisone Market report are Adrenocortical Dysfunction, Adrenergic Syndrome, High Blood Calcium, Thyroiditis, Rheumatoid Arthritis, Dermatitis, Asthma and Chronic Obstructive Pulmonary Disease, Others

What are the Type segmentation covered in the Hydrocortisone Market report?

Ans: The Types covered in the Hydrocortisone Market report are Cream, Injection, Table

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hydrocortisone Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Cream
1.2.3 Injection
1.2.4 Table
1.3 Market by Application
1.3.1 Global Hydrocortisone Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Adrenocortical Dysfunction
1.3.3 Adrenergic Syndrome
1.3.4 High Blood Calcium
1.3.5 Thyroiditis
1.3.6 Rheumatoid Arthritis
1.3.7 Dermatitis
1.3.8 Asthma and Chronic Obstructive Pulmonary Disease
1.3.9 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hydrocortisone Market Perspective (2020-2031)
2.2 Global Hydrocortisone Growth Trends by Region
2.2.1 Global Hydrocortisone Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Hydrocortisone Historic Market Size by Region (2020-2025)
2.2.3 Hydrocortisone Forecasted Market Size by Region (2026-2031)
2.3 Hydrocortisone Market Dynamics
2.3.1 Hydrocortisone Industry Trends
2.3.2 Hydrocortisone Market Drivers
2.3.3 Hydrocortisone Market Challenges
2.3.4 Hydrocortisone Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hydrocortisone Players by Revenue
3.1.1 Global Top Hydrocortisone Players by Revenue (2020-2025)
3.1.2 Global Hydrocortisone Revenue Market Share by Players (2020-2025)
3.2 Global Hydrocortisone Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Hydrocortisone Revenue
3.4 Global Hydrocortisone Market Concentration Ratio
3.4.1 Global Hydrocortisone Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hydrocortisone Revenue in 2024
3.5 Global Key Players of Hydrocortisone Head office and Area Served
3.6 Global Key Players of Hydrocortisone, Product and Application
3.7 Global Key Players of Hydrocortisone, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Hydrocortisone Breakdown Data by Type
4.1 Global Hydrocortisone Historic Market Size by Type (2020-2025)
4.2 Global Hydrocortisone Forecasted Market Size by Type (2026-2031)
5 Hydrocortisone Breakdown Data by Application
5.1 Global Hydrocortisone Historic Market Size by Application (2020-2025)
5.2 Global Hydrocortisone Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Hydrocortisone Market Size (2020-2031)
6.2 North America Hydrocortisone Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Hydrocortisone Market Size by Country (2020-2025)
6.4 North America Hydrocortisone Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hydrocortisone Market Size (2020-2031)
7.2 Europe Hydrocortisone Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Hydrocortisone Market Size by Country (2020-2025)
7.4 Europe Hydrocortisone Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hydrocortisone Market Size (2020-2031)
8.2 Asia-Pacific Hydrocortisone Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Hydrocortisone Market Size by Region (2020-2025)
8.4 Asia-Pacific Hydrocortisone Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hydrocortisone Market Size (2020-2031)
9.2 Latin America Hydrocortisone Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Hydrocortisone Market Size by Country (2020-2025)
9.4 Latin America Hydrocortisone Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hydrocortisone Market Size (2020-2031)
10.2 Middle East & Africa Hydrocortisone Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Hydrocortisone Market Size by Country (2020-2025)
10.4 Middle East & Africa Hydrocortisone Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Hydrocortisone Introduction
11.1.4 Pfizer Revenue in Hydrocortisone Business (2020-2025)
11.1.5 Pfizer Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Hydrocortisone Introduction
11.2.4 Sanofi Revenue in Hydrocortisone Business (2020-2025)
11.2.5 Sanofi Recent Development
11.3 Teva
11.3.1 Teva Company Details
11.3.2 Teva Business Overview
11.3.3 Teva Hydrocortisone Introduction
11.3.4 Teva Revenue in Hydrocortisone Business (2020-2025)
11.3.5 Teva Recent Development
11.4 Akorn
11.4.1 Akorn Company Details
11.4.2 Akorn Business Overview
11.4.3 Akorn Hydrocortisone Introduction
11.4.4 Akorn Revenue in Hydrocortisone Business (2020-2025)
11.4.5 Akorn Recent Development
11.5 GSK
11.5.1 GSK Company Details
11.5.2 GSK Business Overview
11.5.3 GSK Hydrocortisone Introduction
11.5.4 GSK Revenue in Hydrocortisone Business (2020-2025)
11.5.5 GSK Recent Development
11.6 Bausch and Lomb
11.6.1 Bausch and Lomb Company Details
11.6.2 Bausch and Lomb Business Overview
11.6.3 Bausch and Lomb Hydrocortisone Introduction
11.6.4 Bausch and Lomb Revenue in Hydrocortisone Business (2020-2025)
11.6.5 Bausch and Lomb Recent Development
11.7 Bayer Pharmas
11.7.1 Bayer Pharmas Company Details
11.7.2 Bayer Pharmas Business Overview
11.7.3 Bayer Pharmas Hydrocortisone Introduction
11.7.4 Bayer Pharmas Revenue in Hydrocortisone Business (2020-2025)
11.7.5 Bayer Pharmas Recent Development
11.8 Macleods Pharmaceuticals
11.8.1 Macleods Pharmaceuticals Company Details
11.8.2 Macleods Pharmaceuticals Business Overview
11.8.3 Macleods Pharmaceuticals Hydrocortisone Introduction
11.8.4 Macleods Pharmaceuticals Revenue in Hydrocortisone Business (2020-2025)
11.8.5 Macleods Pharmaceuticals Recent Development
11.9 Casper Pharma
11.9.1 Casper Pharma Company Details
11.9.2 Casper Pharma Business Overview
11.9.3 Casper Pharma Hydrocortisone Introduction
11.9.4 Casper Pharma Revenue in Hydrocortisone Business (2020-2025)
11.9.5 Casper Pharma Recent Development
11.10 Dow Pharma
11.10.1 Dow Pharma Company Details
11.10.2 Dow Pharma Business Overview
11.10.3 Dow Pharma Hydrocortisone Introduction
11.10.4 Dow Pharma Revenue in Hydrocortisone Business (2020-2025)
11.10.5 Dow Pharma Recent Development
11.11 Fougera Pharms
11.11.1 Fougera Pharms Company Details
11.11.2 Fougera Pharms Business Overview
11.11.3 Fougera Pharms Hydrocortisone Introduction
11.11.4 Fougera Pharms Revenue in Hydrocortisone Business (2020-2025)
11.11.5 Fougera Pharms Recent Development
11.12 Hikma Intl Pharms
11.12.1 Hikma Intl Pharms Company Details
11.12.2 Hikma Intl Pharms Business Overview
11.12.3 Hikma Intl Pharms Hydrocortisone Introduction
11.12.4 Hikma Intl Pharms Revenue in Hydrocortisone Business (2020-2025)
11.12.5 Hikma Intl Pharms Recent Development
11.13 Impax Labs
11.13.1 Impax Labs Company Details
11.13.2 Impax Labs Business Overview
11.13.3 Impax Labs Hydrocortisone Introduction
11.13.4 Impax Labs Revenue in Hydrocortisone Business (2020-2025)
11.13.5 Impax Labs Recent Development
11.14 Ivax Pharms
11.14.1 Ivax Pharms Company Details
11.14.2 Ivax Pharms Business Overview
11.14.3 Ivax Pharms Hydrocortisone Introduction
11.14.4 Ivax Pharms Revenue in Hydrocortisone Business (2020-2025)
11.14.5 Ivax Pharms Recent Development
11.15 Lannett
11.15.1 Lannett Company Details
11.15.2 Lannett Business Overview
11.15.3 Lannett Hydrocortisone Introduction
11.15.4 Lannett Revenue in Hydrocortisone Business (2020-2025)
11.15.5 Lannett Recent Development
11.16 Merck
11.16.1 Merck Company Details
11.16.2 Merck Business Overview
11.16.3 Merck Hydrocortisone Introduction
11.16.4 Merck Revenue in Hydrocortisone Business (2020-2025)
11.16.5 Merck Recent Development
11.17 Novartis
11.17.1 Novartis Company Details
11.17.2 Novartis Business Overview
11.17.3 Novartis Hydrocortisone Introduction
11.17.4 Novartis Revenue in Hydrocortisone Business (2020-2025)
11.17.5 Novartis Recent Development
11.18 Salix Pharms
11.18.1 Salix Pharms Company Details
11.18.2 Salix Pharms Business Overview
11.18.3 Salix Pharms Hydrocortisone Introduction
11.18.4 Salix Pharms Revenue in Hydrocortisone Business (2020-2025)
11.18.5 Salix Pharms Recent Development
11.19 Sandoz
11.19.1 Sandoz Company Details
11.19.2 Sandoz Business Overview
11.19.3 Sandoz Hydrocortisone Introduction
11.19.4 Sandoz Revenue in Hydrocortisone Business (2020-2025)
11.19.5 Sandoz Recent Development
11.20 TARO
11.20.1 TARO Company Details
11.20.2 TARO Business Overview
11.20.3 TARO Hydrocortisone Introduction
11.20.4 TARO Revenue in Hydrocortisone Business (2020-2025)
11.20.5 TARO Recent Development
11.21 Valeant
11.21.1 Valeant Company Details
11.21.2 Valeant Business Overview
11.21.3 Valeant Hydrocortisone Introduction
11.21.4 Valeant Revenue in Hydrocortisone Business (2020-2025)
11.21.5 Valeant Recent Development
11.22 Wockhardt
11.22.1 Wockhardt Company Details
11.22.2 Wockhardt Business Overview
11.22.3 Wockhardt Hydrocortisone Introduction
11.22.4 Wockhardt Revenue in Hydrocortisone Business (2020-2025)
11.22.5 Wockhardt Recent Development
11.23 Farmak JSC
11.23.1 Farmak JSC Company Details
11.23.2 Farmak JSC Business Overview
11.23.3 Farmak JSC Hydrocortisone Introduction
11.23.4 Farmak JSC Revenue in Hydrocortisone Business (2020-2025)
11.23.5 Farmak JSC Recent Development
11.24 Solvay Pharma
11.24.1 Solvay Pharma Company Details
11.24.2 Solvay Pharma Business Overview
11.24.3 Solvay Pharma Hydrocortisone Introduction
11.24.4 Solvay Pharma Revenue in Hydrocortisone Business (2020-2025)
11.24.5 Solvay Pharma Recent Development
11.25 Alcon
11.25.1 Alcon Company Details
11.25.2 Alcon Business Overview
11.25.3 Alcon Hydrocortisone Introduction
11.25.4 Alcon Revenue in Hydrocortisone Business (2020-2025)
11.25.5 Alcon Recent Development
11.26 Paladin Labs
11.26.1 Paladin Labs Company Details
11.26.2 Paladin Labs Business Overview
11.26.3 Paladin Labs Hydrocortisone Introduction
11.26.4 Paladin Labs Revenue in Hydrocortisone Business (2020-2025)
11.26.5 Paladin Labs Recent Development
11.27 Adcock Ingram
11.27.1 Adcock Ingram Company Details
11.27.2 Adcock Ingram Business Overview
11.27.3 Adcock Ingram Hydrocortisone Introduction
11.27.4 Adcock Ingram Revenue in Hydrocortisone Business (2020-2025)
11.27.5 Adcock Ingram Recent Development
11.28 ADARE Pharmaceuticals
11.28.1 ADARE Pharmaceuticals Company Details
11.28.2 ADARE Pharmaceuticals Business Overview
11.28.3 ADARE Pharmaceuticals Hydrocortisone Introduction
11.28.4 ADARE Pharmaceuticals Revenue in Hydrocortisone Business (2020-2025)
11.28.5 ADARE Pharmaceuticals Recent Development
11.29 Aspen Holdings
11.29.1 Aspen Holdings Company Details
11.29.2 Aspen Holdings Business Overview
11.29.3 Aspen Holdings Hydrocortisone Introduction
11.29.4 Aspen Holdings Revenue in Hydrocortisone Business (2020-2025)
11.29.5 Aspen Holdings Recent Development
11.30 Astellas Pharma
11.30.1 Astellas Pharma Company Details
11.30.2 Astellas Pharma Business Overview
11.30.3 Astellas Pharma Hydrocortisone Introduction
11.30.4 Astellas Pharma Revenue in Hydrocortisone Business (2020-2025)
11.30.5 Astellas Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Hydrocortisone Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Cream
 Table 3. Key Players of Injection
 Table 4. Key Players of Table
 Table 5. Global Hydrocortisone Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Hydrocortisone Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Hydrocortisone Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Hydrocortisone Market Share by Region (2020-2025)
 Table 9. Global Hydrocortisone Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Hydrocortisone Market Share by Region (2026-2031)
 Table 11. Hydrocortisone Market Trends
 Table 12. Hydrocortisone Market Drivers
 Table 13. Hydrocortisone Market Challenges
 Table 14. Hydrocortisone Market Restraints
 Table 15. Global Hydrocortisone Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Hydrocortisone Market Share by Players (2020-2025)
 Table 17. Global Top Hydrocortisone Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hydrocortisone as of 2024)
 Table 18. Ranking of Global Top Hydrocortisone Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Hydrocortisone Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Hydrocortisone, Headquarters and Area Served
 Table 21. Global Key Players of Hydrocortisone, Product and Application
 Table 22. Global Key Players of Hydrocortisone, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Hydrocortisone Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Hydrocortisone Revenue Market Share by Type (2020-2025)
 Table 26. Global Hydrocortisone Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Hydrocortisone Revenue Market Share by Type (2026-2031)
 Table 28. Global Hydrocortisone Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Hydrocortisone Revenue Market Share by Application (2020-2025)
 Table 30. Global Hydrocortisone Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Hydrocortisone Revenue Market Share by Application (2026-2031)
 Table 32. North America Hydrocortisone Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Hydrocortisone Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Hydrocortisone Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Hydrocortisone Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Hydrocortisone Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Hydrocortisone Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Hydrocortisone Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Hydrocortisone Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Hydrocortisone Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Hydrocortisone Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Hydrocortisone Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Hydrocortisone Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Hydrocortisone Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Hydrocortisone Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Hydrocortisone Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Pfizer Company Details
 Table 48. Pfizer Business Overview
 Table 49. Pfizer Hydrocortisone Product
 Table 50. Pfizer Revenue in Hydrocortisone Business (2020-2025) & (US$ Million)
 Table 51. Pfizer Recent Development
 Table 52. Sanofi Company Details
 Table 53. Sanofi Business Overview
 Table 54. Sanofi Hydrocortisone Product
 Table 55. Sanofi Revenue in Hydrocortisone Business (2020-2025) & (US$ Million)
 Table 56. Sanofi Recent Development
 Table 57. Teva Company Details
 Table 58. Teva Business Overview
 Table 59. Teva Hydrocortisone Product
 Table 60. Teva Revenue in Hydrocortisone Business (2020-2025) & (US$ Million)
 Table 61. Teva Recent Development
 Table 62. Akorn Company Details
 Table 63. Akorn Business Overview
 Table 64. Akorn Hydrocortisone Product
 Table 65. Akorn Revenue in Hydrocortisone Business (2020-2025) & (US$ Million)
 Table 66. Akorn Recent Development
 Table 67. GSK Company Details
 Table 68. GSK Business Overview
 Table 69. GSK Hydrocortisone Product
 Table 70. GSK Revenue in Hydrocortisone Business (2020-2025) & (US$ Million)
 Table 71. GSK Recent Development
 Table 72. Bausch and Lomb Company Details
 Table 73. Bausch and Lomb Business Overview
 Table 74. Bausch and Lomb Hydrocortisone Product
 Table 75. Bausch and Lomb Revenue in Hydrocortisone Business (2020-2025) & (US$ Million)
 Table 76. Bausch and Lomb Recent Development
 Table 77. Bayer Pharmas Company Details
 Table 78. Bayer Pharmas Business Overview
 Table 79. Bayer Pharmas Hydrocortisone Product
 Table 80. Bayer Pharmas Revenue in Hydrocortisone Business (2020-2025) & (US$ Million)
 Table 81. Bayer Pharmas Recent Development
 Table 82. Macleods Pharmaceuticals Company Details
 Table 83. Macleods Pharmaceuticals Business Overview
 Table 84. Macleods Pharmaceuticals Hydrocortisone Product
 Table 85. Macleods Pharmaceuticals Revenue in Hydrocortisone Business (2020-2025) & (US$ Million)
 Table 86. Macleods Pharmaceuticals Recent Development
 Table 87. Casper Pharma Company Details
 Table 88. Casper Pharma Business Overview
 Table 89. Casper Pharma Hydrocortisone Product
 Table 90. Casper Pharma Revenue in Hydrocortisone Business (2020-2025) & (US$ Million)
 Table 91. Casper Pharma Recent Development
 Table 92. Dow Pharma Company Details
 Table 93. Dow Pharma Business Overview
 Table 94. Dow Pharma Hydrocortisone Product
 Table 95. Dow Pharma Revenue in Hydrocortisone Business (2020-2025) & (US$ Million)
 Table 96. Dow Pharma Recent Development
 Table 97. Fougera Pharms Company Details
 Table 98. Fougera Pharms Business Overview
 Table 99. Fougera Pharms Hydrocortisone Product
 Table 100. Fougera Pharms Revenue in Hydrocortisone Business (2020-2025) & (US$ Million)
 Table 101. Fougera Pharms Recent Development
 Table 102. Hikma Intl Pharms Company Details
 Table 103. Hikma Intl Pharms Business Overview
 Table 104. Hikma Intl Pharms Hydrocortisone Product
 Table 105. Hikma Intl Pharms Revenue in Hydrocortisone Business (2020-2025) & (US$ Million)
 Table 106. Hikma Intl Pharms Recent Development
 Table 107. Impax Labs Company Details
 Table 108. Impax Labs Business Overview
 Table 109. Impax Labs Hydrocortisone Product
 Table 110. Impax Labs Revenue in Hydrocortisone Business (2020-2025) & (US$ Million)
 Table 111. Impax Labs Recent Development
 Table 112. Ivax Pharms Company Details
 Table 113. Ivax Pharms Business Overview
 Table 114. Ivax Pharms Hydrocortisone Product
 Table 115. Ivax Pharms Revenue in Hydrocortisone Business (2020-2025) & (US$ Million)
 Table 116. Ivax Pharms Recent Development
 Table 117. Lannett Company Details
 Table 118. Lannett Business Overview
 Table 119. Lannett Hydrocortisone Product
 Table 120. Lannett Revenue in Hydrocortisone Business (2020-2025) & (US$ Million)
 Table 121. Lannett Recent Development
 Table 122. Merck Company Details
 Table 123. Merck Business Overview
 Table 124. Merck Hydrocortisone Product
 Table 125. Merck Revenue in Hydrocortisone Business (2020-2025) & (US$ Million)
 Table 126. Merck Recent Development
 Table 127. Novartis Company Details
 Table 128. Novartis Business Overview
 Table 129. Novartis Hydrocortisone Product
 Table 130. Novartis Revenue in Hydrocortisone Business (2020-2025) & (US$ Million)
 Table 131. Novartis Recent Development
 Table 132. Salix Pharms Company Details
 Table 133. Salix Pharms Business Overview
 Table 134. Salix Pharms Hydrocortisone Product
 Table 135. Salix Pharms Revenue in Hydrocortisone Business (2020-2025) & (US$ Million)
 Table 136. Salix Pharms Recent Development
 Table 137. Sandoz Company Details
 Table 138. Sandoz Business Overview
 Table 139. Sandoz Hydrocortisone Product
 Table 140. Sandoz Revenue in Hydrocortisone Business (2020-2025) & (US$ Million)
 Table 141. Sandoz Recent Development
 Table 142. TARO Company Details
 Table 143. TARO Business Overview
 Table 144. TARO Hydrocortisone Product
 Table 145. TARO Revenue in Hydrocortisone Business (2020-2025) & (US$ Million)
 Table 146. TARO Recent Development
 Table 147. Valeant Company Details
 Table 148. Valeant Business Overview
 Table 149. Valeant Hydrocortisone Product
 Table 150. Valeant Revenue in Hydrocortisone Business (2020-2025) & (US$ Million)
 Table 151. Valeant Recent Development
 Table 152. Wockhardt Company Details
 Table 153. Wockhardt Business Overview
 Table 154. Wockhardt Hydrocortisone Product
 Table 155. Wockhardt Revenue in Hydrocortisone Business (2020-2025) & (US$ Million)
 Table 156. Wockhardt Recent Development
 Table 157. Farmak JSC Company Details
 Table 158. Farmak JSC Business Overview
 Table 159. Farmak JSC Hydrocortisone Product
 Table 160. Farmak JSC Revenue in Hydrocortisone Business (2020-2025) & (US$ Million)
 Table 161. Farmak JSC Recent Development
 Table 162. Solvay Pharma Company Details
 Table 163. Solvay Pharma Business Overview
 Table 164. Solvay Pharma Hydrocortisone Product
 Table 165. Solvay Pharma Revenue in Hydrocortisone Business (2020-2025) & (US$ Million)
 Table 166. Solvay Pharma Recent Development
 Table 167. Alcon Company Details
 Table 168. Alcon Business Overview
 Table 169. Alcon Hydrocortisone Product
 Table 170. Alcon Revenue in Hydrocortisone Business (2020-2025) & (US$ Million)
 Table 171. Alcon Recent Development
 Table 172. Paladin Labs Company Details
 Table 173. Paladin Labs Business Overview
 Table 174. Paladin Labs Hydrocortisone Product
 Table 175. Paladin Labs Revenue in Hydrocortisone Business (2020-2025) & (US$ Million)
 Table 176. Paladin Labs Recent Development
 Table 177. Adcock Ingram Company Details
 Table 178. Adcock Ingram Business Overview
 Table 179. Adcock Ingram Hydrocortisone Product
 Table 180. Adcock Ingram Revenue in Hydrocortisone Business (2020-2025) & (US$ Million)
 Table 181. Adcock Ingram Recent Development
 Table 182. ADARE Pharmaceuticals Company Details
 Table 183. ADARE Pharmaceuticals Business Overview
 Table 184. ADARE Pharmaceuticals Hydrocortisone Product
 Table 185. ADARE Pharmaceuticals Revenue in Hydrocortisone Business (2020-2025) & (US$ Million)
 Table 186. ADARE Pharmaceuticals Recent Development
 Table 187. Aspen Holdings Company Details
 Table 188. Aspen Holdings Business Overview
 Table 189. Aspen Holdings Hydrocortisone Product
 Table 190. Aspen Holdings Revenue in Hydrocortisone Business (2020-2025) & (US$ Million)
 Table 191. Aspen Holdings Recent Development
 Table 192. Astellas Pharma Company Details
 Table 193. Astellas Pharma Business Overview
 Table 194. Astellas Pharma Hydrocortisone Product
 Table 195. Astellas Pharma Revenue in Hydrocortisone Business (2020-2025) & (US$ Million)
 Table 196. Astellas Pharma Recent Development
 Table 197. Research Programs/Design for This Report
 Table 198. Key Data Information from Secondary Sources
 Table 199. Key Data Information from Primary Sources
 Table 200. Authors List of This Report


List of Figures
 Figure 1. Hydrocortisone Picture
 Figure 2. Global Hydrocortisone Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Hydrocortisone Market Share by Type: 2024 VS 2031
 Figure 4. Cream Features
 Figure 5. Injection Features
 Figure 6. Table Features
 Figure 7. Global Hydrocortisone Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Hydrocortisone Market Share by Application: 2024 VS 2031
 Figure 9. Adrenocortical Dysfunction Case Studies
 Figure 10. Adrenergic Syndrome Case Studies
 Figure 11. High Blood Calcium Case Studies
 Figure 12. Thyroiditis Case Studies
 Figure 13. Rheumatoid Arthritis Case Studies
 Figure 14. Dermatitis Case Studies
 Figure 15. Asthma and Chronic Obstructive Pulmonary Disease Case Studies
 Figure 16. Others Case Studies
 Figure 17. Hydrocortisone Report Years Considered
 Figure 18. Global Hydrocortisone Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 19. Global Hydrocortisone Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 20. Global Hydrocortisone Market Share by Region: 2024 VS 2031
 Figure 21. Global Hydrocortisone Market Share by Players in 2024
 Figure 22. Global Top Hydrocortisone Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hydrocortisone as of 2024)
 Figure 23. The Top 10 and 5 Players Market Share by Hydrocortisone Revenue in 2024
 Figure 24. North America Hydrocortisone Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. North America Hydrocortisone Market Share by Country (2020-2031)
 Figure 26. United States Hydrocortisone Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Canada Hydrocortisone Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Europe Hydrocortisone Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Europe Hydrocortisone Market Share by Country (2020-2031)
 Figure 30. Germany Hydrocortisone Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. France Hydrocortisone Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. U.K. Hydrocortisone Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Italy Hydrocortisone Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Russia Hydrocortisone Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Nordic Countries Hydrocortisone Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Hydrocortisone Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Asia-Pacific Hydrocortisone Market Share by Region (2020-2031)
 Figure 38. China Hydrocortisone Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Japan Hydrocortisone Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. South Korea Hydrocortisone Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Hydrocortisone Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. India Hydrocortisone Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Australia Hydrocortisone Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Latin America Hydrocortisone Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Latin America Hydrocortisone Market Share by Country (2020-2031)
 Figure 46. Mexico Hydrocortisone Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Brazil Hydrocortisone Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Middle East & Africa Hydrocortisone Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Middle East & Africa Hydrocortisone Market Share by Country (2020-2031)
 Figure 50. Turkey Hydrocortisone Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Hydrocortisone Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. UAE Hydrocortisone Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 53. Pfizer Revenue Growth Rate in Hydrocortisone Business (2020-2025)
 Figure 54. Sanofi Revenue Growth Rate in Hydrocortisone Business (2020-2025)
 Figure 55. Teva Revenue Growth Rate in Hydrocortisone Business (2020-2025)
 Figure 56. Akorn Revenue Growth Rate in Hydrocortisone Business (2020-2025)
 Figure 57. GSK Revenue Growth Rate in Hydrocortisone Business (2020-2025)
 Figure 58. Bausch and Lomb Revenue Growth Rate in Hydrocortisone Business (2020-2025)
 Figure 59. Bayer Pharmas Revenue Growth Rate in Hydrocortisone Business (2020-2025)
 Figure 60. Macleods Pharmaceuticals Revenue Growth Rate in Hydrocortisone Business (2020-2025)
 Figure 61. Casper Pharma Revenue Growth Rate in Hydrocortisone Business (2020-2025)
 Figure 62. Dow Pharma Revenue Growth Rate in Hydrocortisone Business (2020-2025)
 Figure 63. Fougera Pharms Revenue Growth Rate in Hydrocortisone Business (2020-2025)
 Figure 64. Hikma Intl Pharms Revenue Growth Rate in Hydrocortisone Business (2020-2025)
 Figure 65. Impax Labs Revenue Growth Rate in Hydrocortisone Business (2020-2025)
 Figure 66. Ivax Pharms Revenue Growth Rate in Hydrocortisone Business (2020-2025)
 Figure 67. Lannett Revenue Growth Rate in Hydrocortisone Business (2020-2025)
 Figure 68. Merck Revenue Growth Rate in Hydrocortisone Business (2020-2025)
 Figure 69. Novartis Revenue Growth Rate in Hydrocortisone Business (2020-2025)
 Figure 70. Salix Pharms Revenue Growth Rate in Hydrocortisone Business (2020-2025)
 Figure 71. Sandoz Revenue Growth Rate in Hydrocortisone Business (2020-2025)
 Figure 72. TARO Revenue Growth Rate in Hydrocortisone Business (2020-2025)
 Figure 73. Valeant Revenue Growth Rate in Hydrocortisone Business (2020-2025)
 Figure 74. Wockhardt Revenue Growth Rate in Hydrocortisone Business (2020-2025)
 Figure 75. Farmak JSC Revenue Growth Rate in Hydrocortisone Business (2020-2025)
 Figure 76. Solvay Pharma Revenue Growth Rate in Hydrocortisone Business (2020-2025)
 Figure 77. Alcon Revenue Growth Rate in Hydrocortisone Business (2020-2025)
 Figure 78. Paladin Labs Revenue Growth Rate in Hydrocortisone Business (2020-2025)
 Figure 79. Adcock Ingram Revenue Growth Rate in Hydrocortisone Business (2020-2025)
 Figure 80. ADARE Pharmaceuticals Revenue Growth Rate in Hydrocortisone Business (2020-2025)
 Figure 81. Aspen Holdings Revenue Growth Rate in Hydrocortisone Business (2020-2025)
 Figure 82. Astellas Pharma Revenue Growth Rate in Hydrocortisone Business (2020-2025)
 Figure 83. Bottom-up and Top-down Approaches for This Report
 Figure 84. Data Triangulation
 Figure 85. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String